These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1867965)

  • 1. Stereoselective pharmacokinetics of disopyramide and interaction with cimetidine.
    Bonde J; Pedersen LE; Nygaard E; Ramsing T; Angelo HR; Kampmann JP
    Br J Clin Pharmacol; 1991 Jun; 31(6):708-10. PubMed ID: 1867965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man.
    Hasselström J; Enquist M; Hermansson J; Dahlqvist R
    Eur J Clin Pharmacol; 1991; 41(5):481-4. PubMed ID: 1761078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man.
    Jou MJ; Huang SC; Kiang FM; Lai MY; Chao PD
    J Pharm Pharmacol; 1997 Nov; 49(11):1072-5. PubMed ID: 9401940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits.
    Horikawa M; Yasumuro M; Kanno M; Hanada K; Hashiguchi M; Ogata H
    J Pharm Pharmacol; 2001 Dec; 53(12):1621-8. PubMed ID: 11804392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective inhibition of pindolol renal clearance by cimetidine in humans.
    Somogyi AA; Bochner F; Sallustio BC
    Clin Pharmacol Ther; 1992 Apr; 51(4):379-87. PubMed ID: 1563208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo interaction of the enantiomers of disopyramide in human subjects.
    Giacomini KM; Nelson WL; Pershe RA; Valdivieso L; Turner-Tamiyasu K; Blaschke TF
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):335-56. PubMed ID: 3772736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pharmacokinetics and metabolism of disopyramide enantiomers.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic activity and unbound concentrations of disopyramide enantiomers in patients.
    Lima JJ; Wenzke SC; Boudoulas H; Schaal SF
    Ther Drug Monit; 1990 Jan; 12(1):23-8. PubMed ID: 2305417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective pharmacokinetics of disopyramide enantiomers in man.
    Lima JJ; Boudoulas H; Shields BJ
    Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias.
    Le Corre P; Gibassier D; Descaves C; Sado P; Daubert JC; Le Verge R
    J Clin Pharmacol; 1989 Dec; 29(12):1089-96. PubMed ID: 2482304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cimetidine coadministration on the pharmacokinetics of sotalol enantiomers in an anaesthetized rat model: evidence supporting active renal excretion of sotalol.
    Carr RA; Pasutto FM; Foster RT
    Biopharm Drug Dispos; 1996 Jan; 17(1):55-69. PubMed ID: 8991491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
    Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
    J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action.
    Mikus G; Eichelbaum M; Fischer C; Gumulka S; Klotz U; Kroemer HK
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1042-8. PubMed ID: 2359015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen.
    Evans AM; Nation RL; Sansom LN
    Br J Clin Pharmacol; 1989 Aug; 28(2):143-9. PubMed ID: 2775619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
    Aso R; Ohashi K; Katoh T; Ogata H
    Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of two disopyramide capsules in humans based on total, unbound, and unbound enantiomer concentrations.
    Takahashi H; Ogata H; Shimizu M; Hashimoto K; Masuhara K; Kashiwada K; Someya K
    Biopharm Drug Dispos; 1993 Jul; 14(5):409-18. PubMed ID: 8218959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disopyramide pharmacokinetics and metabolism: effect of inducers.
    Kapil RP; Axelson JE; Mansfield IL; Edwards DJ; McErlane B; Mason MA; Lalka D; Kerr CR
    Br J Clin Pharmacol; 1987 Dec; 24(6):781-91. PubMed ID: 3440098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans.
    le Corre P; Malledant Y; Chevanne F; Sado P; le Verge R
    Chirality; 1992; 4(2):80-3. PubMed ID: 1616827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.